Ko E - Search Results

1

Methylation and Immunoexpression of p16(INK4a) Tumor Suppressor Gene in Primary Breast Cancer Tissue and Their Quantitative p16(INK4a) Hypermethylation in Plasma by Real-Time PCR.

Lee JJ, Ko E, Cho J, Park HY, Lee JE, Nam SJ, Kim DH, Cho EY. Lee JJ, et al. Among authors: ko e. Korean J Pathol. 2012 Dec;46(6):554-61. doi: 10.4132/KoreanJPathol.2012.46.6.554. Epub 2012 Dec 26. Korean J Pathol. 2012. PMID: 23323106 Free PMC article.

2

Aberrant DNA methylation of integrin α4 in human breast cancer.

Do SI, Ko E, Kang SY, Lee JE, Nam SJ, Cho EY, Kim DH. Do SI, et al. Among authors: ko e. Tumour Biol. 2014 Jul;35(7):7079-84. doi: 10.1007/s13277-014-1952-7. Epub 2014 Apr 24. Tumour Biol. 2014. PMID: 24756760

3

Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancer.

Ko E, Park SE, Cho EY, Kim Y, Hwang JA, Lee YS, Nam SJ, Bang S, Park J, Kim DH. Ko E, et al. Breast Cancer Res. 2010;12(6):R100. doi: 10.1186/bcr2783. Epub 2010 Nov 23. Breast Cancer Res. 2010. PMID: 21092257 Free PMC article.

4

Synergistic effect of Bcl-2 and cyclin A2 on adverse recurrence-free survival in stage I non-small cell lung cancer.

Ko E, Kim Y, Cho EY, Han J, Shim YM, Park J, Kim DH. Ko E, et al. Ann Surg Oncol. 2013 Mar;20(3):1005-12. doi: 10.1245/s10434-012-2727-2. Epub 2012 Nov 1. Ann Surg Oncol. 2013. PMID: 23115005

5

Association of RASSF1A and p63 with poor recurrence-free survival in node-negative stage I-II non-small cell lung cancer.

Ko E, Lee BB, Kim Y, Lee EJ, Cho EY, Han J, Shim YM, Park J, Kim DH. Ko E, et al. Clin Cancer Res. 2013 Mar 1;19(5):1204-12. doi: 10.1158/1078-0432.CCR-12-2848. Epub 2013 Jan 14. Clin Cancer Res. 2013. PMID: 23319821

6

CpG island hypermethylation of SOCS-1 gene is inversely associated with HBV infection in hepatocellular carcinoma.

Ko E, Kim SJ, Joh JW, Park CK, Park J, Kim DH. Ko E, et al. Cancer Lett. 2008 Nov 28;271(2):240-50. doi: 10.1016/j.canlet.2008.06.009. Epub 2008 Jul 18. Cancer Lett. 2008. PMID: 18639978

7

Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.

Ko E, Kim Y, Kim SJ, Joh JW, Song S, Park CK, Park J, Kim DH. Ko E, et al. Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2260-7. doi: 10.1158/1055-9965.EPI-08-0236. Epub 2008 Aug 22. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18723830

8

Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer.

Ko E, Kim Y, Park SE, Cho EY, Han J, Shim YM, Park J, Kim DH. Ko E, et al. Lung Cancer. 2012 Aug;77(2):401-6. doi: 10.1016/j.lungcan.2012.03.027. Epub 2012 Apr 24. Lung Cancer. 2012. PMID: 22534667

9

Cohypermethylation of p14 in combination with CADM1 or DCC as a recurrence-related prognostic indicator in stage I esophageal squamous cell carcinoma.

Lee E, Lee BB, Ko E, Kim Y, Han J, Shim YM, Park J, Kim DH. Lee E, et al. Among authors: ko e. Cancer. 2013 May 1;119(9):1752-60. doi: 10.1002/cncr.27948. Epub 2013 Jan 10. Cancer. 2013. PMID: 23310950 Free article.

10

Relationship of phospho-pRb (Ser-807/811) level to exposure to tobacco smoke in primary non-small cell lung cancer.

Ko E, Kim Y, Lee BB, Han J, Song SY, Shim YM, Park J, Kim DH. Ko E, et al. Cancer Lett. 2009 Feb 18;274(2):225-32. doi: 10.1016/j.canlet.2008.09.016. Epub 2008 Oct 19. Cancer Lett. 2009. PMID: 18938028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,757 results

Search Page

Filters